|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.4758 USD | +1.57% |
|
-0.50% | -86.89% |
| 04-08 | Kineta, Inc. Reports Initial Clinical Response Data at AACR 2024 of its Ongoing Phase 1/2 Vista-101 Clinical Trial | CI |
| 03-21 | Earnings Flash (KA) KINETA Posts 2023 Revenue $5.4M | MT |
Kineta, Inc. reported earnings results for the first quarter ended March 31, 2023. For the first quarter, the company reported revenue was USD 0.281 million compared to USD 0.433 million a year ago. Net loss was USD 6.45 million compared to USD 4.98 million a year ago.
Basic loss per share from continuing operations was USD 0.77 compared to USD 1.07 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| -86.89% | 5.4M | |
| +9.99% | 115B | |
| +12.01% | 106B | |
| -3.07% | 24.69B | |
| -0.67% | 21.97B | |
| -4.64% | 19.27B | |
| -6.90% | 17.56B | |
| -39.36% | 17.32B | |
| +5.82% | 14.03B | |
| +33.05% | 12.13B |
KINETA, INC. 
